US 9006201
Prophylactic or therapeutic agent for diabetes
granted A61KA61K31/7088A61K31/7105
Quick answer
US patent 9006201 (Prophylactic or therapeutic agent for diabetes) held by Takeda Pharmaceutical Company Limited expires Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/7088, A61K31/7105, A61P, A61P3/10